TASC (Telehealth After Stroke Care): a study protocol for a randomized controlled feasibility trial of telehealth-enabled multidisciplinary stroke care in an underserved urban setting

Imama A Naqvi, Ying Kuen Cheung, Kevin Strobino, Hanlin Li, Sarah E Tom, Zehra Husaini, Olajide A Williams, Randolph S Marshall, Adriana Arcia, Ian M Kronish, Mitchell S V Elkind, Imama A Naqvi, Ying Kuen Cheung, Kevin Strobino, Hanlin Li, Sarah E Tom, Zehra Husaini, Olajide A Williams, Randolph S Marshall, Adriana Arcia, Ian M Kronish, Mitchell S V Elkind

Abstract

Background: Hypertension is the most important modifiable risk factor for recurrent stroke, and blood pressure (BP) reduction is associated with decreased risk of stroke recurrence. However, hypertension remains poorly controlled in many stroke survivors. Black and Hispanic patients have a higher prevalence of uncontrolled BP and higher rates of stroke. Limited access to care contributes to challenges in post-stroke care. Telehealth After Stroke Care (TASC) is a telehealth intervention that integrates remote BP monitoring (RBPM) including nursing telephone support, tailored BP infographics and telehealth video visits with a multidisciplinary team approach including pharmacy to improve post-stroke care and reduce stroke disparities.

Methods: In this pilot trial, 50 acute stroke patients with hypertension will be screened for inclusion prior to hospital discharge and randomized to usual care or TASC. Usual care patients will be seen by a primary care nurse practitioner at 1-2 weeks and a stroke neurologist at 1 and 3 months. In addition to these usual care visits, TASC intervention patients will see a pharmacist at 4 and 8 weeks and will be enrolled in RBPM consisting of home BP monitoring with interval calls by a centralized team of telehealth nurses. As part of RBPM, TASC patients will be provided with a home BP monitoring device and electronic tablet that wirelessly transmits home BP data to the electronic health record. They will also receive tailored BP infographics that help explain their BP readings. The primary outcome will be feasibility including recruitment, adherence to at least one video visit and retention rates. The clinical outcome for consideration in a subsequent trial will be within-patient change in BP from baseline to 3 months after discharge. Secondary outcomes will be medication adherence self-efficacy and satisfaction with post-stroke telehealth, both measured at 3 months. Additional patient reported outcomes will include depression, cognitive function, and socioeconomic determinants. Multidisciplinary team competency and fidelity measures will also be assessed.

Conclusions: Integrated team-based interventions may improve BP control and reduce racial/ethnic disparities in post-stroke care. TASC is a post-acute stroke care model that is novel in providing RBPM with tailored infographics, and a multidisciplinary team approach including pharmacy. Our pilot will determine if such an approach is feasible and effective in enhancing post-stroke BP control and promoting self-efficacy.

Trial registration: ClinicalTrials.gov NCT04640519.

Keywords: StrokeHypertension, Multidisciplinary, Telehealth, Disparities, Self-efficacy.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Telehealth after stroke care (TASC): multidisciplinary access with remote BP monitoring intervention versus usual care
Fig. 2
Fig. 2
Remote BP patient monitoring overview of system workflow
Fig. 3
Fig. 3
Tailored BP infographics used to conduct motivational interview regarding control

References

    1. Mozaffarian D, et al. Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation. 2015;131(4):e29–e322.
    1. Ovbiagele B, et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013;44(8):2361–2375. doi: 10.1161/STR.0b013e31829734f2.
    1. Virani SS, et al. Heart disease and stroke statistics-2021 update. Circulation. 2021;143(8):e254–e743. doi: 10.1161/CIR.0000000000000950.
    1. Cruz-Flores S, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(7):2091–2116. doi: 10.1161/STR.0b013e3182213e24.
    1. Rosamond WD, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30(4):736–743. doi: 10.1161/01.STR.30.4.736.
    1. Sacco RL, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147(3):259–268. doi: 10.1093/oxfordjournals.aje.a009445.
    1. Kissela B, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35(2):426–431. doi: 10.1161/01.STR.0000110982.74967.39.
    1. Schieb LJ, et al. Trends and disparities in stroke mortality by region for American Indians and Alaska Natives. Am J Public Health. 2014;104(Suppl 3):S368–S376. doi: 10.2105/AJPH.2013.301698.
    1. Morgenstern LB, et al. Excess stroke in Mexican Americans compared with non-Hispanic whites: the Brain attack surveillance in Corpus Christi project. Am J Epidemiol. 2004;160(4):376–383. doi: 10.1093/aje/kwh225.
    1. Morgenstern LB, et al. Loss of the Mexican American survival advantage after ischemic stroke. Stroke. 2014;45(9):2588–2591. doi: 10.1161/STROKEAHA.114.005429.
    1. O’Donnell MJ, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi: 10.1016/S0140-6736(16)30506-2.
    1. Group PC Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–1041. doi: 10.1016/S0140-6736(01)06178-5.
    1. Kernan WN, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236. doi: 10.1161/STR.0000000000000024.
    1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi: 10.1136/bmj.b1665.
    1. Liu L, et al. Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res. 2009;32(11):1032–1040. doi: 10.1038/hr.2009.139.
    1. Brenner DA, et al. Awareness, treatment, and control of vascular risk factors among stroke survivors. J Stroke Cerebrovasc Dis. 2010;19(4):311–320. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.001.
    1. Zahuranec DB, et al. Poor long-term blood pressure control after intracerebral hemorrhage. Stroke. 2012;43(10):2580–2585. doi: 10.1161/STROKEAHA.112.663047.
    1. White CL, et al. Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens. 2013;26(9):1114–1122. doi: 10.1093/ajh/hpt076.
    1. Benjamin EJ, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528. doi: 10.1161/CIR.0000000000000659.
    1. Ireland SE, et al. Stroke prevention care delivery: predictors of risk factor management outcomes. Int J Nurs Stud. 2011;48(2):156–164. doi: 10.1016/j.ijnurstu.2010.07.003.
    1. Dave GJ, et al. Predictors of uncontrolled hypertension in the Stroke Belt. J Clin Hypertens (Greenwich) 2013;15(8):562–569. doi: 10.1111/jch.12122.
    1. Aronow WS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011;5(4):259–352. doi: 10.1016/j.jash.2011.06.001.
    1. Bridgwood B, et al. Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev. 2018;5:CD009103.
    1. Khan NA, et al. Antihypertensive drug use and adherence after stroke: are there sex differences? Stroke. 2010;41(7):1445–1449. doi: 10.1161/STROKEAHA.110.579375.
    1. Joubert J, et al. Integrated care improves risk-factor modification after stroke: initial results of the Integrated Care for the Reduction of Secondary Stroke model. J Neurol Neurosurg Psychiatry. 2009;80(3):279–284. doi: 10.1136/jnnp.2008.148122.
    1. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34(11):2741–2748. doi: 10.1161/01.STR.0000092488.40085.15.
    1. Lindblad A, Howorko J. Integration of a pharmacist into a stroke prevention clinic team. Can J Hosp Pharm. 2008;61(6).
    1. McManus RJ, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808. doi: 10.1001/jama.2014.10057.
    1. Mills KT, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168(2):110–120. doi: 10.7326/M17-1805.
    1. Ajinkya S, et al. Racial/ethnic disparities in acute ischemic stroke treatment within a telestroke network. Telemed J E Health. 2020;26(10):1221–5.
    1. Patel UK, et al. Multidisciplinary approach and outcomes of tele-neurology: a review. Cureus. 2019;11(4):e4410.
    1. Al Kasab S, Almallouhi E, Holmstedt CA. Optimizing the use of teleneurology during the COVID-19 pandemic. Telemed J E Health. 2020;26(10):1197–1198. doi: 10.1089/tmj.2020.0109.
    1. Ye S, et al. Telemedicine expansion during the COVID-19 pandemic and the potential for technology-driven disparities. J Gen Intern Med. 2021;36(1):256–8.
    1. Naqvi IA, et al. Internet access and usage among stroke survivors and their informal caregivers: cross-sectional study. JMIR Form Res. 2021;5(3):e25123. doi: 10.2196/25123.
    1. Chen MJ, et al. A telehealth service model for the treatment of hypertension. J Telemed Telecare. 2013;19(5):238–241. doi: 10.1177/1357633X13495476.
    1. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17(4):535. doi: 10.1007/s11906-015-0535-3.
    1. Buis L, et al. Text messaging to improve hypertension medication adherence in African Americans from primary care and emergency department settings: results from two randomized feasibility studies. JMIR Mhealth Uhealth. 2017;5(2):e9. doi: 10.2196/mhealth.6630.
    1. Whelton PK, et al. Research needs to improve hypertension treatment and control in African Americans. Hypertension. 2016;68(5):1066–1072. doi: 10.1161/HYPERTENSIONAHA.116.07905.
    1. Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13(2):209–221. doi: 10.1586/14779072.2015.1001368.
    1. Sisson EM, et al. Effectiveness of a pharmacist-physician team-based collaboration to improve long-term blood pressure control at an inner-city safety-net clinic. Pharmacotherapy. 2016;36(3):342–347. doi: 10.1002/phar.1710.
    1. Shireman TI, Svarstad BL. cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients. J Am Pharm Assoc (2003) 2016;56(4):389–396. doi: 10.1016/j.japh.2016.03.002.
    1. Ruppar TM, et al. Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis. J Hypertens. 2017;35(6):1145–1154. doi: 10.1097/HJH.0000000000001260.
    1. Margolis KL, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46–56. doi: 10.1001/jama.2013.6549.
    1. Lager KE, et al. Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev. 2014;5:CD009103.
    1. Spruill TM, et al. Comparative effectiveness of home blood pressure telemonitoring (HBPTM) plus nurse case management versus HBPTM alone among Black and Hispanic stroke survivors: study protocol for a randomized controlled trial. Trials. 2015;16:97. doi: 10.1186/s13063-015-0605-5.
    1. Duncan PW, et al. Randomized pragmatic trial of stroke transitional care. Circ Cardiovasc Qual Outcomes. 2020;13(6):e006285. doi: 10.1161/CIRCOUTCOMES.119.006285.
    1. Shippee ND, et al. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041–1051. doi: 10.1016/j.jclinepi.2012.05.005.
    1. Oelke ND, et al. Indicators and measurement tools for health system integration: a knowledge synthesis protocol. Syst Rev. 2015;4:99. doi: 10.1186/s13643-015-0090-7.
    1. Dawes M. Why is controlling blood pressure after stroke so difficult? CMAJ. 2013;185(1):11–12. doi: 10.1503/cmaj.121819.
    1. Condon C, et al. Reducing readmissions after stroke with a structured nurse practitioner/registered nurse transitional stroke program. Stroke. 2016;47(6):1599–1604. doi: 10.1161/STROKEAHA.115.012524.
    1. Basaraba JE, et al. Pharmacists as care providers for stroke patients: a systematic review. Can J Neurol Sci. 2018;45(1):49–55. doi: 10.1017/cjn.2017.233.
    1. Andres J, et al. Pharmacists’ impact on secondary stroke prevention. J Pharm Pract. 2019;32(5):503–508. doi: 10.1177/0897190018766944.
    1. Andres J, et al. Drug therapy management in a pharmacist-run stroke prevention clinic. Am J Health Syst Pharm. 2016;73(18):1388–1390. doi: 10.2146/ajhp150773.
    1. Kripalani S, et al. PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10.
    1. Neil WP, et al. Mail order pharmacy use and adherence to secondary prevention drugs among stroke patients. J Neurol Sci. 2018;390:117–120. doi: 10.1016/j.jns.2018.04.001.
    1. Margolis KL, et al. Cardiovascular events and costs with home blood pressure telemonitoring and pharmacist management for uncontrolled hypertension. Hypertension. 2020;76(4):1097–1103. doi: 10.1161/HYPERTENSIONAHA.120.15492.
    1. Houle SK, et al. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN) Pharmacotherapy. 2012;32(6):527–537. doi: 10.1002/j.1875-9114.2012.01097.x.
    1. McCrorie AD, Donnelly C, McGlade KJ. infographics: healthcare communication for the digital age. Ulster Med J. 2016;85(2):71–75.
    1. Arcia A, et al. Sometimes more is more: iterative participatory design of infographics for engagement of community members with varying levels of health literacy. J Am Med Inform Assoc. 2016;23(1):174–183. doi: 10.1093/jamia/ocv079.
    1. Gardener H, et al. Race and ethnic disparities in stroke incidence in the Northern Manhattan Study. Stroke. 2020;51(4):1064–1069. doi: 10.1161/STROKEAHA.119.028806.
    1. Li H, et al. Integrating neurology and pharmacy through telemedicine: a novel care model. J Neurol Sci. 2021;432:120085. doi: 10.1016/j.jns.2021.120085.
    1. Moher D, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869.
    1. NYS Pharmacy: Laws, Rules & Regulations: Article 137. Available from: . Cited 2021 03/06/2021.
    1. Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(6):1269–324.
    1. Bakken S, et al. Development, validation, and use of English and Spanish versions of the telemedicine satisfaction and usefulness questionnaire. J Am Med Inform Assoc. 2006;13(6):660–667. doi: 10.1197/jamia.M2146.
    1. Aboelela SW, et al. Defining interdisciplinary research: conclusions from a critical review of the literature. Health Serv Res. 2007;42(1 Pt 1):329–346. doi: 10.1111/j.1475-6773.2006.00621.x.
    1. Gebbie KM, et al. Training for interdisciplinary health research: defining the required competencies. J Allied Health. 2008;37(2):65–70.
    1. Hessels AJ, et al. Building interdisciplinary research models through interactive education. Clin Transl Sci. 2015;8(6):793–799. doi: 10.1111/cts.12354.
    1. Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011;8(3):319–329. doi: 10.1007/s13311-011-0053-1.
    1. Arsava EM, et al. Prediction of early recurrence after acute ischemic stroke. JAMA Neurol. 2016;73(4):396–401. doi: 10.1001/jamaneurol.2015.4949.
    1. Liotta EM, et al. Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission. Crit Care Med. 2013;41(12):2762–2769. doi: 10.1097/CCM.0b013e318298a10f.
    1. Vahidy FS, et al. Nationwide estimates of 30-day readmission in patients with ischemic stroke. Stroke. 2017;48(5):1386–1388. doi: 10.1161/STROKEAHA.116.016085.
    1. Fehnel CR, et al. Post-acute care data for predicting readmission after ischemic stroke: a nationwide cohort analysis using the minimum data set. J Am Heart Assoc. 2015;4(9):e002145. doi: 10.1161/JAHA.115.002145.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit